AUS
NZ
UK
CA
USA
IND
Highlights:
- Fleet delays: Airbus delivery setbacks are expected to slow Wizz Air’s capacity growth, impacting its expansion plans.
- Fleet adjustments: Wizz Air has switched to larger A321 NEO aircraft for better seat cost economics, but profitability concerns remain.
- High leverage: The airline's elevated debt levels, compared to competitors, continue to raise concerns about its financial health and growth potential.
Panmure Liberum has reiterated its 'sell' rating on Wizz Air Holdings PLC (LSE:WIZZ), citing ongoing concerns about the airline's high leverage and challenges to growing profitably. Alongside its cautious outlook, the broker has reduced its target price for the airline from 1,200p to 1,100p, pointing to delays in aircraft deliveries from Airbus as a key factor affecting Wizz Air’s future growth trajectory.
Fleet Expansion Delays Raise Concerns
Wizz Air has faced significant delays in expanding its fleet due to supply chain disruptions from Airbus, which will slow down the airline's capacity growth in the coming years. Panmure Liberum believes this could affect Wizz Air's ability to execute its long-term growth plans. Although the slower growth rate may mitigate some concerns about oversupply, the broker remains worried about the airline's capacity to expand profitably under these constraints.
Adjustments to Fleet Plan
In response to the delays, Wizz Air has adjusted its fleet plan by switching its remaining A320 NEO orders to the larger A321 NEO aircraft, which offers better seat cost economics. This move is intended to enhance operational efficiency and address the challenges posed by the Airbus delays. However, Panmure Liberum still questions the airline's ability to leverage these changes for long-term profitability.
Leverage and Debt Issues Persist
A key factor driving the broker’s cautious outlook is Wizz Air's high debt levels, particularly when compared to competitors like Ryanair and easyJet. The airline continues to grapple with its elevated leverage, which, according to Panmure Liberum, could hinder its financial performance and ability to invest in future growth. This concern over its financial health remains central to the broker's decision to maintain a 'sell' rating on the stock.
